Nova Leap Health Corp. Named #10 2019 TSX Venture Performer

Press Release – February 21, 2019 (1122 downloads)

HALIFAX, February 21, 2019 – NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or the “Company”), a company focused on the home health care industry, is pleased to announce it has achieved the #10 ranking in the 2019 TSX Venture 50™ in the Clean Technology & Life Sciences sector.  The TSX Venture 50™ is the TSX Venture Exchange’s annual ranking of Canada’s top 50 emerging publicly traded companies.

“We are pleased to have been recognized as one of the top performing companies in the TSX Venture Exchange,” said Chris Dobbin, President & CEO of Nova Leap Health Corp. “This recognition stems from having talented people in the U.S. and Canada to execute on our strategy.  We remain steadfast to our long-term plan of building a very large multi-national organization aimed at providing high-quality home care to our current clients and to those that will require assistance in the future.”

The TSX Venture 50™ acknowledges the top 10 performing companies listed on the TSX Venture Exchange in five industry sectors: mining, oil & gas, clean technology & life sciences, diversified industries, and technology. The winners are selected based on three equally weighted criteria: market capitalization growth, share price appreciation and trading volume. The TSXV created a video profile on Nova Leap and other 2019 TSX Venture 50™ winners, available at

About Nova Leap

The Home Care Providers industry is becoming one of the fastest growing healthcare industries in the United States and Canada. Home care saves patients billions of dollars every year by treating them in their own homes instead of in hospitals. An aging population, the prevalence of chronic disease, growing physician acceptance of home care, medical advancements and a movement toward cost-efficient treatment options from public and private payers have all fostered industry growth.  Nova Leap is focused on a highly fragmented market of small privately-held companies providing patients one on one care in their homes.  Nova Leap’s post acquisition organic growth strategy is to increase annual revenue per location through a combination of increased employee investment, including training, focused sales and marketing efforts, billing rate increases, expansion of geographical coverage, and improved referral sources.


Certain information in this press release may contain forward-looking statements. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in the Company’s filings with the Canadian securities regulators, which filings are available at

For further information:

Christopher Dobbin, CPA, CA,
Director, President and CEO Nova Leap Health Corp.,
T: 902 401 9480   F:  902 482 5177


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


7071 Bayers Road, Suite 3006
Halifax, Nova Scotia Canada B3L 2C2


Chris Dobbin
President & CEO